lifestyle.smarttalksuccess.com

Author: SN BIOSCIENCE

SN BioScience Doses First Patient in Phase 1b/2 Clinical Trial of ‘SNB-101’

May 14, 2026
SN BioScience received US FDA Orphan Drug Designation for its Nano Anti-Cancer Drug ‘SNB-101’ on Gastric Cancer.

December 23, 2025